<prompt> Which of the following drug is used curvently for the prophylaxis of non infectious uveitis in LUMINATE programmeCyclosporineVoclosporineMethotrexatelnfli xi mib  <response>: B i.e. Voclosporine - LUMINATE i.e. Lux Uveitis Multicentre Investigations of a New Approch Treatment programme is a scientific drug trial staed in 2007 and completed in 2009 for uveitis. In this programme a pivotal study LUVENIQ LX-211 assessed the safety and efficacy of oral form of next generation calcineurin inhibitor, Voclosporin for treatment of sight threatening non infectious uveitis as a steroid sparing therapy. - LX - 212 Programme : In this a bioerodible polymer implant containing voclosporin is implanted, using minimally invasive approach; which release active ingradient slowly steadily to the surface of eye. - LX - 214 Programme : In this topical formulation eye drop of nanomicelles of voclosporin which in not normally soluble in aqueous media is used for dry eye, atopic kerato conjunctivitis blepharitis. LUMITECT Programme and LUCIDA LX-201 i.e. Lux Corneal Transplant Implant Development Advancement of Therapy Study : In this silicon matrix ocular episcleralimplant that steadily releases therapeutic dose of cyclosporine A is used for prevention of rejection of corneal transplant. 